India
· Delayed Price · Currency is INR Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of INR 282.00 billion. The enterprise value is 262.48 billion.
| Market Cap | 282.00B |
| Enterprise Value | 262.48B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | Aug 21, 2024 |
Share Statistics
Pfizer has 45.75 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Shares Outstanding | 45.75M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 18.47% |
| Float | 15.14M |
Valuation Ratios
The trailing PE ratio is 46.34.
| PE Ratio | 46.34 |
| Forward PE | n/a |
| PS Ratio | 12.68 |
| PB Ratio | 7.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 43.13 |
| EV / Sales | 11.80 |
| EV / EBITDA | 37.38 |
| EV / EBIT | 40.96 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 2.63 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | n/a |
| Interest Coverage | 43.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 11.39% |
| Revenue Per Employee | 12.93M |
| Profits Per Employee | 3.54M |
| Employee Count | 1,721 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +60.12% in the last 52 weeks. The beta is 0.28, so Pfizer's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +60.12% |
| 50-Day Moving Average | 5,447.67 |
| 200-Day Moving Average | 4,643.54 |
| Relative Strength Index (RSI) | 67.00 |
| Average Volume (20 Days) | 71,719 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pfizer had revenue of INR 22.25 billion and earned 6.09 billion in profits. Earnings per share was 133.01.
| Revenue | 22.25B |
| Gross Profit | 14.47B |
| Operating Income | 6.41B |
| Pretax Income | 8.23B |
| Net Income | 6.09B |
| EBITDA | 7.02B |
| EBIT | 6.41B |
| Earnings Per Share (EPS) | 133.01 |
Balance Sheet
The company has 20.47 billion in cash and 945.40 million in debt, giving a net cash position of 19.52 billion or 426.72 per share.
| Cash & Cash Equivalents | 20.47B |
| Total Debt | 945.40M |
| Net Cash | 19.52B |
| Net Cash Per Share | 426.72 |
| Equity (Book Value) | 35.96B |
| Book Value Per Share | 785.76 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 65.06%, with operating and profit margins of 28.80% and 27.35%.
| Gross Margin | 65.06% |
| Operating Margin | 28.80% |
| Pretax Margin | 36.99% |
| Profit Margin | 27.35% |
| EBITDA Margin | 31.56% |
| EBIT Margin | 28.80% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.57%.
| Dividend Per Share | 35.00 |
| Dividend Yield | 0.57% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.56% |
| Earnings Yield | 2.16% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |